After After
Before Before

90004 - Ki-67 APP, Breast Cancer

INTRODUCTION

The Ki-67 protein is associated with cellular proliferation, and the protein is present in the nucleus of all cells that are in the active phase of the cell cycle, but absent in resting cells[1]. The cell proliferation rate can be assessed by Ki-67-immunohistochemical (IHC) staining, and this can be correlated to the tumor grade and the clinical course[2].

This protocol can be used to assess tumors by determining the Ki-67 positivity. The protocol detects and classifies nuclei as positive or negative and returns an average proliferation index for the entire tumor region. Tumor regions must be identified and outlined manually within a region of interest (ROI). Calibration of the protocol allows it to be used on images with different staining intensities.

KEYWORDS

Cancer, Breast cancer, Ki-67, Ki67, Proliferation index, Digital pathology, Image analysis, IHC

METHODS

The APP works within an automatically or manually outlined tumor region of interest (ROI) [See FIGURE 1]. Within each ROI, nuclei are detected and classified into Ki-67 positive or negative. The first image processing step involves a segmentation of all nuclei in the ROI. The HDAB-DAB color deconvolution band is used to detect positively stained nuclei and a multiplication of the red and blue color band is used to detect negative nuclei. A method for nucleus separation which is based on shape, size and nuclei probability is used, employing a fully automated watershed-based nucleus segmentation technique. As a post-processing step, nuclei areas that are too small are removed. The image obtained after post-processing is used to determine the output variables.

Note on counting: Analysis of full virtual slides takes place in a tile-by-tile fashion. If not handled appropriately, nuclei that are intersecting with neighboring tile boundaries would be counted twice (or more). By using unbiased counting frames[3], this can be avoided [See FIGURE 2]. This principle is implemented in the present APP. Depending on the size of nuclei, the application of this principle could make an important difference.

QUANTITATIVE OUTPUT VARIABLES

The output variables obtained from this protocol are:

  • Neg Nuclei (#): The number of Ki-67 negative nuclei within all ROIs
  • Pos Nuclei (#): The number of Ki-67 positive nuclei within all ROIs
  • Total Nuclei (#): The total number of nuclei within all ROIs
  • Proliferation index (%): The Ki-67 proliferation index


AUXILIARY APPS

No auxiliary APPs are included.

WORKFLOW

Step 1: Manually outline tumor areas as regions of interest (ROIs)

Step 2: Load and run 90004 Ki-67 APP, Breast Cancer to analyze the nuclei in tumor region(s)

STAINING PROTOCOL

There is no staining protocol available.

ADDITIONAL INFORMATION

The APP utilizes the EngineTM and Viewer software modules, where EngineTM offers an execution platform to expand processing capability and speed of image analysis. Viewer gives a fast review together with several types of image adjustment properties ex. outlining of regions, annotations and direct measures of distance, curve length, radius, etc.

REFERENCES

LITERATURE

1. The Ki-67 protein: from the known and the unknown, T. Scholzen et al., J. Cell Physiol. 2000, 182 (3): 311-22

2. www.nordiqc.org/epitope.php?id=1

3. Unbiased Stereology, C.V. Howard & M.G. Reed, QTP Publications

CE IVD
FIGURE 1
FIGURE 1
Manual outline of tumor region.
FIGURE 2
FIGURE 2
Ki-67 analysis with classification of positive (red) and negative (blue) nuclei. Using un-biased counting frames in the detection of nuclei ensures that each object is counted only once.
FIGURE 3
FIGURE 3
Finished Ki-67 analysis within the outlined tumor region.